VITA, GIANLUCA
 Distribuzione geografica
Continente #
EU - Europa 2.811
NA - Nord America 2.781
AS - Asia 704
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 1
SA - Sud America 1
Totale 6.309
Nazione #
US - Stati Uniti d'America 2.773
IE - Irlanda 895
CN - Cina 610
SE - Svezia 593
IT - Italia 401
PL - Polonia 296
DE - Germania 239
FI - Finlandia 114
GB - Regno Unito 98
UA - Ucraina 67
FR - Francia 65
IN - India 55
BE - Belgio 28
VN - Vietnam 20
EU - Europa 9
CA - Canada 8
HK - Hong Kong 7
RU - Federazione Russa 5
ES - Italia 3
KR - Corea 3
IR - Iran 2
NL - Olanda 2
PH - Filippine 2
SG - Singapore 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
JP - Giappone 1
KZ - Kazakistan 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RO - Romania 1
TW - Taiwan 1
Totale 6.309
Città #
Dublin 895
Chandler 624
Nyköping 380
Warsaw 296
Beijing 259
Jacksonville 234
Ashburn 216
Princeton 177
Medford 141
Ann Arbor 137
Cambridge 115
Messina 103
Des Moines 88
Dearborn 62
Bremen 59
Lancaster 59
Shenyang 55
Pune 53
San Mateo 49
Boardman 48
Wilmington 43
New York 41
Jinan 39
Houston 31
Tianjin 31
Nanjing 29
Brussels 26
Rome 25
Hebei 23
Ningbo 23
Zhengzhou 23
Dong Ket 20
Hangzhou 20
Nürnberg 17
Woodbridge 15
Palo Del Colle 13
Nanchang 12
Taizhou 12
Haikou 11
Norwalk 11
Guangzhou 10
Changsha 9
Jiaxing 8
Fuzhou 7
Hong Kong 7
Taiyuan 7
Riposto 6
Seattle 6
Fairfield 5
Falls Church 5
Helsinki 5
Leawood 5
Catania 4
Fort Worth 4
Segrate 4
Taranto 4
Augusta 3
Caserta 3
Clearwater 3
Hanover 3
Lanzhou 3
London 3
Mannheim 3
Milan 3
Monza 3
Napoli 3
Northampton 3
Nynäshamn 3
Piazza Armerina 3
San Antonio 3
Strasbourg 3
Toronto 3
Washington 3
Xiangfen 3
Alicante 2
Amsterdam 2
Ardabil 2
Bari 2
Batangas 2
Bergamo 2
Cagliari 2
Frosinone 2
Galluccio 2
Glasgow 2
Kemerovo 2
Modena 2
Namdong-gu 2
Palermo 2
Riva 2
Salerno 2
San Giuliano Milanese 2
San Vito Di Leguzzano 2
Sint-Truiden 2
Tappahannock 2
Atlanta 1
Auckland 1
Benevento 1
Bern 1
Bonavista 1
Buffalo 1
Totale 4.711
Nome #
Severe rhabdomyolysis in a patient with “Heat Stroke” 192
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 128
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 101
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 91
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy 89
Hippo signaling pathway is altered in Duchenne muscular dystrophy 84
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 74
The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice. 70
Histological effects of givinostat in boys with Duchenne muscular dystrophy 69
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 69
Sport activity in Charcot-Marie-Tooth disease: A case study of a Paralympic swimmer 68
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 66
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 65
Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study 63
Effect of exercise on telomere length and telomere proteins expression in mdx mice 63
Muscle Fat-Fraction and Mapping in Duchenne Muscular Dystrophy: Evaluation of Disease Distribution and Correlation with Clinical Assessments: A preliminary experience. 62
Pilot study of flavocoxid in ambulant DMD patients. 62
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 62
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 61
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 60
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 60
The 24-month PUL changes and steroids correlation. 60
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 60
Pilot study of serial casting in muscular dystrophy patients. 59
Pilot study of serial casting of ankles in muscular dystrophy patients. 59
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 59
Pilot study of flavocoxid in ambulant DMD patients. 58
Benefits of glucocorticoids in non-ambulant boys/men with Duchenne muscular dystrophy: A multicentric longitudinal study using the Performance of Upper Limb test 58
Nusinersen versus sham control in later-onset spinal muscular atrophy 58
Outcome measures in Duchenne muscular dystrophy: validation of the Pediatric Quality of Life InventoryTM Neuromuscular Module in the Italian population and correlation with other functional assessments. 57
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 56
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 55
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 55
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 55
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury. 55
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 54
MYH7-related myopathies: Clinical, histopathological and imaging findings in a cohort of Italian patients 53
Predictors of adaptation to non-invasive ventilation in amyotrophic lateral sclerosis 53
Psycological status and emotional burden in amyotrophic lateral sclerosis caregivers: the role of metacognitive processes. 53
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 53
Severe rhabdomyolysis in a patient with “Heat Stroke” 52
ANT1 is reduced in sporadic inclusion body myositis. 52
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 51
Predictors of adaptation to non-invasive ventilation in neuromuscular disorders. 51
Autonomic nervous system involvement in spinal muscular atrophy. 51
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 51
Long term natural history data in ambulant boys with Duchenne muscular dystrophy: 36-month changes 49
First report of a family with a DMD out of frame exon 2 deletion associated with asymptomatic phenotypes. 49
Impaired myocardial deformation revealing subclinical left ventricular dysfunction in children with Duchenne dystrophy: a speckle tracking echocardiography study 49
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 2: diseases of motor neuron and skeletal muscle 49
Cardiac function in types II and III spinal muscular atrophy: should we change standards of care? 48
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 48
Miopatia prossimale in paziente con sindrome di Williams 47
Dual-echo dual flip angle gradient-echo MRI technique for quantification of muscle fat fraction in Duchenne muscular dystrophy: a new valuable outcome measure. 47
Telomere shortening and telomere associated proteins in exercised wild type and mdx mice. 47
Dolori muscolari, deficit di forza e/o disturbi sensitivi 47
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 47
Flavocoxid counteracts muscle necrosis and improves functional properties in mdx mice: a comparison study with methylprednisolone 46
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 46
Impaired myocardial strain in early stage of Duchenne muscular dystrophy: its relation with age and motor performance 46
Emergenze respiratorie nelle malattie neurologiche 45
FSHD and Williams syndrome: the occurrence of two genetic disorders due to heterozygous DNA fragment deletions in the same patient. 44
L'inibizione dei pathway del fattore nucleare-kappaB, delle MAP chinasi e di COX/5-LOX mediante trattamento con flavocoxid migliora la funzione e la morfologia muscolare nel topo mdx: uno studio comparativo con il metilprednisolone 44
Amyloid myopathy presenting with rhabdomyolysis. 44
Selective short-term verbal memory involvement in two siblings carrying centronuclear myopathy due to DNM2 gene mutations 44
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with Duchenne muscular dystrophy: a skeckle tracking study. 44
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 44
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis 44
null 43
null 43
Psychosocial impact of presymptomatic genetic testing for transthyretin amyloidotic polyneuropathy 43
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 43
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 43
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 42
Burden, professional support, and social network in families of children and young adults with muscular dystrophies 42
null 42
Impaired rotational mechanics and strain revealing subclinical left ventricular dysfunction in children with neuromuscolar disorders: a speckle tracking study 41
Gene expression profile in transthyretin related familial amyloidotic polyneuropathy 40
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 40
study of flavocoxid in ambulant DMD patients. 40
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 40
Burden, social network and professional support in the families of patients with muscular dystrophies: results from the GUP10002 study. 40
Psychosocial impact of sport activity in neuromuscular disorders 40
Safety and effectiveness of ataluren: comparison of results from the STRIDE Registry and CINRG DMD Natural History Study 40
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy 39
6 min walking test 12 month changes in DMD: Correlation with genotype. 39
Timed rise from floor as a predictor of disease progression in Duchenne muscular dystrophy: An observational study 39
New aspects on patients affected by dysferlin deficient muscular dystrophy. 38
Longitudinal natural history in young boys with Duchenne muscular dystrophy 38
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 38
Molecular profile of transthyretin related familial amyloidotic polyneuropathy: a microarray analysis. 37
Role of calcineurin/NFAT on muscle regeneration in dystrophic process. 36
Stato dell'arte sulle terapie della Distrofia muscolare di Duchenne. 36
Dolori muscolari, deficit di forza e/o disturbi sensitivi 36
Clinical and pathological features of focal myositis 35
Regulation of SIRT1 in Duchenne Muscular Dystrophy by miRNA-34a. 35
Teriparatide (rhPTH) treatment in Duchenne Muscular Dystrophy, a case report. 35
Bone quality in Duchenne muscular dystrophy 35
The first report of a patient carrying an out-of-frame exon2 deletion in the dystrophin gene and showing a very unusual phenotype. 34
“I have got something positive out of this situation”: Psychological benefits of caregiving in relatives of young people with muscular dystrophy 33
Totale 5.300
Categoria #
all - tutte 24.689
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.689


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201928 0 0 0 0 0 0 0 0 0 18 5 5
2019/2020966 54 19 5 34 13 87 93 88 59 265 169 80
2020/2021932 54 47 212 39 237 52 74 41 22 80 36 38
2021/2022957 10 97 4 64 48 6 95 38 33 94 88 380
2022/20232.417 196 230 125 160 204 203 18 115 1.092 6 57 11
2023/2024590 31 116 35 83 55 176 37 41 5 11 0 0
Totale 6.640